Andy I. M. Hoepelman

16.0k citations

255 papers · 10.5k indexed · 2 hit papers · h-index 53

Virology top 0.5%
- HIV Research and Treatment 43
Infectious Diseases top 0.2%
- HIV/AIDS drug development and treatment 49
- HIV/AIDS Research and Interventions 42
Epidemiology top 0.2%
- Pneumonia and Respiratory Infections 34
- Urinary Tract Infections Management 28
- Hepatitis B Virus Studies 28
- Pneumocystis jirovecii pneumonia detection and treatment 25
Applied Microbiology and Biotechnology top 0.5%
Hepatology top 1%
- Hepatitis C virus research 35

Co-authors: Suzanne E. Geerlings Jan Jelrik Oosterheert Eelko Hak Roos E. Barth K. J. Gorter Guy E.H.M. Rutten Rob Schuurman François Schellevis
Cited by: Virology Infectious Diseases Epidemiology
Journals: New England Journal of Medicine (3 papers)Proceedings of the National Academy of Sciences (1 paper)The Lancet (1 paper)
Partner nations: Netherlands United States Germany

In The Last Decade

Andy I. M. Hoepelman

252 papers receiving 10.2k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Andy I. M. Hoepelman

Since Specialization

Citations

This map shows the geographic impact of Andy I. M. Hoepelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy I. M. Hoepelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy I. M. Hoepelman more than expected).

Fields of papers citing papers by Andy I. M. Hoepelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy I. M. Hoepelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy I. M. Hoepelman. The network helps show where Andy I. M. Hoepelman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andy I. M. Hoepelman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andy I. M. Hoepelman Line = papers co-authored together Andy I. M. Hoepelman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Selective decline of intact HIV reservoirs during the first decade of ART followed by stabilization in memory T cell subsets AIDS ·Marieke M. Nühn,Kobus J. Bosman,Terry Huisman,Wouter Staring,Lavina Gharu,Dorien de Jong,Theun M. de Kort,Ninée V.E.J. Buchholtz,Kiki Tesselaar,Aridaman Pandit,Joop E. Arends,Sigrid A. Otto,Eduardo Lucio de Esesarte,Andy I. M. Hoepelman,Rob J. de Boer,Jori Symons,José A. M. Borghans,Annemarie M. J. Wensing,Monique Nijhuis	2025	1
2	Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen Viruses ·A. Stam,Ninée V. E. J. Buchholtz,Wouter F.W. Bierman,Reinout van Crevel,Andy I. M. Hoepelman,Mark A. A. Claassen,Heidi Ammerlaan,Berend J. van Welzen,M.E.E. van Kasteren,S.F.L. van Lelyveld,Dorien de Jong,Kiki Tesselaar,Matthijs van Luin,Monique Nijhuis,Annemarie M. J. Wensing,(unknown)	2024	2
3	Integrated analysis of viral blips, residual viremia, and associated factors in people with HIV: Results from a retrospective cohort study Journal of Medical Virology ·Patrick G. A. Oomen,Suzan Dijkstra,L. Marije Hofstra,Monique Nijhuis,Annelies Verbon,Tania Mudrikova,Annemarie M. J. Wensing,Andy I. M. Hoepelman,Berend J. van Welzen	2023	3
4	No increased risk of mature B-cell non-Hodgkin lymphoma after Q fever detected: results from a 16-year ecological analysis of the Dutch population incorporating the 2007–2010 Q fever outbreak International Journal of Epidemiology ·Jesper M. Weehuizen,Sonja E. van Roeden,Sander J Hogewoning,Wim van der Hoek,Marc J. M. Bonten,Andy I. M. Hoepelman,Chantal P. Bleeker‐Rovers,Peter C. Wever,Jan Jelrik Oosterheert	2022	5
5	No Influence of Previous Coxiella burnetii Infection on ICU Admission and Mortality in Emergency Department Patients Infected with SARS-CoV-2 Journal of Clinical Medicine ·Jesper M. Weehuizen,Rik van Spronsen,Andy I. M. Hoepelman,Chantal P. Bleeker‐Rovers,Jan Jelrik Oosterheert,Peter C. Wever	2022	1
6	An open‐label cluster‐randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID‐19 (ARCHAIC)—Protocol publication European Journal of Clinical Investigation ·Jesper M. Weehuizen,Andy I. M. Hoepelman	2020	5
7	Coxiella burnetii in non-Hodgkin lymphoma tissue samples: Innocent until proven otherwise? Immunobiology ·Sonja E. van Roeden,Mirjam H. A. Hermans,Peet Nooijen,A H E Herbers,Chantal P. Bleeker‐Rovers,Andy I. M. Hoepelman,Jan Jelrik Oosterheert,Peter C. Wever	2018	8
8	Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection. SHILAP Revista de lepidopterología ·Faydra I. Lieveld,Niels Swaans,Astrid M. Newsum,Cynthia K. Y. Ho,Janke Schinkel,Richard Molenkamp,Jan T. M. van der Meer,Joop E. Arends,Andy I. M. Hoepelman,A. M. J. Wensing,Peter D. Siersema,Karel J. van Erpecum,Greet J. Boland	2017	2
9	Diagnostic, therapeutic and economic consequences of a positive urinary antigen test for Legionella spp. in patients admitted with community-acquired pneumonia: a 7-year retrospective evaluation Journal of Clinical Pathology ·M. F. Engel,Labrinus van Manen,Andy I. M. Hoepelman,Steven Thijsen,Jan Jelrik Oosterheert	2013	14
10	Human African trypanosomiasis: a review of non-endemic cases in the past 20 years International Journal of Infectious Diseases ·Stephanie J Migchelsen,Philippe Büscher,Andy I. M. Hoepelman,Henk D. F. H. Schallig,Emily R. Adams	2011	41
11	Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus Gastroenterology ·T.E.M.S. de Vries-Sluijs,Jurriën G.P. Reijnders,Bettina E. Hansen,Hans L. Zaaijer,Jan M. Prins,Suzan D. Pas,Martin Schutten,Andy I. M. Hoepelman,Clemens Richter,Jan W. Mulder,Rob A. de Man,Harry L.A. Janssen,Marc van der Valk	2010	85
12	Increasing resistance in community-acquired urinary tract infections in Latin America, five years after the implementation of national therapeutic guidelines International Journal of Infectious Diseases ·Paul Bours,Roel Polak,Andy I. M. Hoepelman,Edgar Delgado,Alvaro J. Monliel Jarquin,Armando Matute	2010	55
13	Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia compared with the general Dutch population Clinical Microbiology and Infection ·Anke H. W. Bruns,Jan Jelrik Oosterheert,Marloes C. Cucciolillo,Rachida el Moussaoui,Rolf H. H. Groenwold,Jan M. Prins,Andy I. M. Hoepelman	2010	1
14	Pneumonia Recovery; Discrepancies in Perspectives of the Radiologist, Physician and Patient Journal of General Internal Medicine ·Anke H. W. Bruns,Jan Jelrik Oosterheert,Rachida el Moussaoui,Brent C. Opmeer,Andy I. M. Hoepelman,Jan M. Prins	2009	39
15	Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance: evidence of transmitted resistance in rural South Africa AIDS ·Roos E. Barth,Annemarie M. J. Wensing,Hugo A. Tempelman,Robert Moraba,Rob Schuurman,Andy I. M. Hoepelman	2008	52
16	Impact of Rapid Detection of Viral and Atypical Bacterial Pathogens by Real-Time Polymerase Chain Reaction for Patients with Lower Respiratory Tract Infection Clinical Infectious Diseases ·Jan Jelrik Oosterheert,Anton M. van Loon,Rob Schuurman,Andy I. M. Hoepelman,Eelko Hak,Steven Thijsen,G.D. Nossent,M. M. E. Schneider,Willem M. N. Hustinx,Marc J. M. Bonten	2005	152
17	O -Acetylation of Cryptococcal Capsular Glucuronoxylomannan Is Essential for Interference with Neutrophil Migration The Journal of Immunology ·Pauline M. Ellerbroek,Dirk J. Lefeber,Richard van Veghel,Jelle Scharringa,Ellen C. Brouwer,Gerrit J. Gerwig,Guilhem Janbon,Andy I. M. Hoepelman,Frank E. J. Coenjaerts	2004	50
18	Potent Inhibition of Neutrophil Migration by Cryptococcal Mannoprotein-4-Induced Desensitization The Journal of Immunology ·Frank E. J. Coenjaerts,Annemiek Walenkamp,Pauline N. M. Mwinzi,Jelle Scharringa,Huberta A. T. Dekker,Jos A. G. van Strijp,Robert Cherniak,Andy I. M. Hoepelman	2001	36
19	Immune dysfunction in patients with diabetes mellitus (DM)breakdown → FEMS Immunology & Medical Microbiology ·Suzanne E. Geerlings,Andy I. M. Hoepelman	1999	943
20	Deficient antipneumococcal polysaccharide responses in HIV-seropositive patients FEMS Immunology & Medical Microbiology ·A. Eduard Loeliger,Ger T. Rijkers,Piet C. Aerts,Annemieke Been-Tiktak,Andy I. M. Hoepelman,Johannes van Dijk,Jan C.C. Borleffs	1995	21

About Andy I. M. Hoepelman

Andy I. M. Hoepelman is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 255 papers that have together received 10.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (49 papers), HIV Research and Treatment (43 papers), HIV/AIDS Research and Interventions (42 papers), Hepatitis C virus research (35 papers), Pneumonia and Respiratory Infections (34 papers), Urinary Tract Infections Management (28 papers), Hepatitis B Virus Studies (28 papers) and Pneumocystis jirovecii pneumonia detection and treatment (25 papers). The work is most often cited by research in Virology (1.3k citations), Infectious Diseases (4.1k citations) and Epidemiology (5.3k citations). Andy I. M. Hoepelman has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Suzanne E. Geerlings, Jan Jelrik Oosterheert, Eelko Hak, Roos E. Barth, K. J. Gorter, Guy E.H.M. Rutten, Rob Schuurman, François Schellevis, Marc J. M. Bonten and Jan C.C. Borleffs. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact